| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 6e-05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |